The post ACOSOG Z0011 era: Does our new understanding of breast cancer really change clinical practice?

European Journal of Surgical Oncology

Volumn 38, Issue 8, 2012, Pages 645-650

  Guth U ^a,b,c   Myrick, M E ^d   Viehl, C T ^b,e   Schmid, S M ^f   Obermann, E C ^b,g   Weber, W P ^b,e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UHB   (Switzerland)

^c CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e Institute for Pathology ^*  (Switzerland)

^f Hospital Grabs   (Switzerland)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

ACOSOG Z0011 trial; Axillary lymph node dissection; Breast cancer; Frozen section; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMORBIDITY; EUROPE; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; UNIVERSITY HOSPITAL;

EID: 84863719140     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.04.018     Document Type: Article

References (32)

1. G.H. Lyman, A.E. Giuliano, and M.R. Somerfield American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 2005 7703 7720 (Pubitemid 46291835)
2. B. Fisher, J.H. Jeong, and S. Anderson Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation N Engl J Med 347 2002 567 575
3. G. Martelli, P. Boracchi, and M. De Palo A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up Ann Surg 242 2005 1 6 discussion 7-9 (Pubitemid 40917960)
4. C.M. Rudenstam, D. Zahrieh, and J.F. Forbes Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93 J Clin Oncol 24 2006 337 344 (Pubitemid 46630451)
5. E.J. Rutgers Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases J Clin Oncol 26 2008 698 702 (Pubitemid 351264381)
6. U. Veronesi, R. Orecchia, and S. Zurrida Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy Ann Oncol 16 2005 383 388 (Pubitemid 40458313)
7. A.E. Giuliano, K.K. Hunt, and K.V. Ballman Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 2011 569 575
8. A.E. Giuliano, L. McCall, and P. Beitsch Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 2010 426 432 discussion 432-423
9. A.S. Caudle, K.K. Hunt, and H.M. Kuerer Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial Ann Surg Oncol 18 2011 2407 2412
10. American Society of Clinical Oncology (ASCO). ASCO Perspective on JAMA breast cancer lymph node study findings. Available: http://www.racheldultzmd. com/ASCO.pdf. [accessed 20.1.2012].
11. B.G. Haffty, K.K. Hunt, J.R. Harris, and T.A. Buchholz Positive sentinel nodes without axillary dissection: implications for the radiation oncologist J Clin Oncol 29 2011 4479 4481
12. M. Morrow, and A.E. Giuliano To cut is to cure: can we really apply Z11 in practice? Ann Surg Oncol 18 2011 2413 2415
13. S. Olsen, B. Amr, and A. Omar Are the findings of ACOSOG Z0011 applicable to district general hospital unit- and how should they change our practice Cancer Res 71 2011 355s 356s
14. D. Lannin, B. Killelea, and B. Grube How generalizable is the patient population enrolled in ACOSOG Z11? Cancer Res 71 2011 366s 367s
15. C. Chalmers, E. Mallon, and S. Stallard The potential impact of applying the Z11 trial to our practice in UK Cancer Res 71 2011 368s
16. W. Yeow, E. Thomee, and N. Roche ACOSOG Z0011: are the results applicable to patients undergoing sentinel node biopsy in a UK breast unit Eur J Surg Oncol 37 2011 S11 S12
17. I. Langer, U. Guller, and G. Berclaz Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients Ann Surg 245 2007 452 461 (Pubitemid 46673142)
18. I. Langer, U. Guller, and S.F. Hsu-Schmitz Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients Eur J Surg Oncol 35 2009 805 813
19. I. Langer, U. Guller, and G. Berclaz Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study Breast Cancer Res Treat 113 2009 129 136
20. Y.G. Fan, Y.Y. Tan, and C.T. Wu The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer Ann Surg Oncol 12 2005 705 711
21. J.S. Fant, M.D. Grant, and S.M. Knox Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection Ann Surg Oncol 10 2003 126 130 (Pubitemid 40485931)
22. K. Fournier, A. Schiller, R.R. Perry, and C. Laronga Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection Ann Surg 239 2004 859 863 discussion 863-855
23. J.M. Guenther, N.M. Hansen, and L.A. DiFronzo Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes Arch Surg 138 2003 52 56 (Pubitemid 36055648)
24. A. Haid, M. Knauer, and R. Koberle-Wuhrer Medium-term follow-up data after sentinel node biopsy alone for breast cancer Eur J Surg Oncol 32 2006 1180 1185 (Pubitemid 44793674)
25. R.F. Hwang, A.M. Gonzalez-Angulo, and M. Yi Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection Cancer 110 2007 723 730 (Pubitemid 47257646)
26. I. Langer, U. Guller, and C.T. Viehl Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study Ann Surg Oncol 16 2009 3366 3374
27. P. Schrenk, P. Konstantiniuk, and S. Wolfl Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node Br J Surg 92 2005 707 713 (Pubitemid 40863189)
28. K.Y. Bilimoria, D.J. Bentrem, and N.M. Hansen Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 2009 2946 2953
29. W.P. Weber, M. Barry, and M.M. Stempel A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete? Ann Surg Oncol 19 2012 225 232
30. K. Hergan, A. Haid, G. Zimmermann, and W. Oser Preoperative axillary ultrasound in breast carcinoma: value of the method in routine clinical practice Ultraschall Med 17 1996 14 17 (Pubitemid 26106434)
31. Y.S. Rajesh, S. Ellenbogen, and B. Banerjee Preoperative axillary ultrasound scan: its accuracy in assessing the axillary nodal status in carcinoma breast Breast 11 2002 49 52 (Pubitemid 34144788)
32. H.G. Strauss, D. Lampe, G. Methfessel, and J. Buchmann Preoperative axilla sonography in breast tumor suspected of malignancy-a diagnostic advantage? Ultraschall Med 19 1998 70 77 (Pubitemid 28243491)